Glaucoma News and Research

Latest Glaucoma News and Research

Oak Ridge technology used to understand semiconductor defects helps people at risk of becoming blind

Millions of people at risk of becoming blind could one day be helped by an Oak Ridge National Laboratory technology originally intended to understand semiconductor defects.

10 Feb 2005

FDA approves Enablex for the treatment of overactive bladder

Novartis Pharmaceuticals Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Enablex® (darifenacin) extended-release tablets (7.5mg and 15mg) for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and frequency.

22 Dec 2004

Confusion over Lasik eye surgery terminology

The Eye Surgery Education Council of the American Society of Cataract and Refractive Surgery Foundation today issued a clarification on the use of the terms "wavefront-guided," and "wavefront-optimized" in connection with laser-based procedures (LASIK, PRK, etc.) and implantable lenses used for vision correction purposes.

20 Dec 2004

Detrol LA significantly reduces symptoms of overactive bladder

Pfizer today announced results of a comprehensive six-year review of efficacy and safety data for Detrol LA (tolterodine tartrate extended release capsules) indicating that Detrol LA significantly reduces symptoms of overactive bladder (OAB) with a low occurrence of side effects, and should be considered first-line therapy.

13 Dec 2004

Instructions provided with medicines is far too small for people with impaired or partially sighted vision to read

When you're in your local pharmacy, do you ever try to compare the lables on products, only to find that the print is impossible to read? A new study goes a little way to remedy this, at least for those who are visually impaired.

16 Nov 2004

Computer use may be linked to the development of glaucoma

So, you spend all or part of your day working with computers. Then take notice, a new Japanese study has found that computer use may be linked to the development of glaucoma (an increase in fluid pressure inside the eye that may lead to loss of vision), especially among those who are short sighted.

16 Nov 2004

McGuinty Government introduces changes to eye care services

The McGuinty government is making changes to the way OHIP insures routine eye exams, Health and Long-Term Care Minister George Smitherman announced today.

1 Nov 2004

Drug-loaded contact lenses to treat eye diseases

When a person suffers from eye ailments today, nine times out of ten, he will be prescribed eye drops to treat his illness or relieve his discomfort.

29 Oct 2004

A unique new non-invasive technique for high resolution optical imaging of the eye

The technique, pioneered by the University of Kent, is funded by the Toronto-based company, Ophthalmic Technology Inc (OTI). The University’s Applied Optics Group is currently working with university hospitals in New York (USA), Osaka (Japan), Asahikawa (Japan), Amsterdam (Netherlands) and Milan (Italy) to carry out preliminary clinical trials.

12 Oct 2004

Significance of central corneal thickness on the management of glaucoma

In a new study, researchers at Columbia University Medical Center demonstrated the significance of central corneal thickness (CCT) on the clinical management of patients with glaucoma and those suspected to have glaucoma.

23 Sep 2004

THC in marijuana may block the spread of forms of cancer causing herpes viruses

The compound in marijuana that produces a high, delta-9 tetrahydrocannbinol or THC, may block the spread of several forms of cancer causing herpes viruses, University of South Florida College of Medicine scientists report.

22 Sep 2004

Cancer drug effective at treating lupus

A drug now used to treat a type of cancer appears to be very effective at treating lupus, with just one injection easing symptoms in several patients for a year or more.

16 Sep 2004

New glaucoma risk assessment principles help physicians decide who needs treatment

A new approach for assessing glaucoma risk factors could be the first step in helping ophthalmologists determine the risk of progression from ocular hypertension to glaucoma and blindness, according to an article published today in the September issue of the American Journal of Ophthalmology.

14 Sep 2004

Thickness of the cornea an important factor in considering treatment options for patients with glaucoma

Thickness of the cornea, the thin, transparent layer covering the eye, may be an important factor in considering treatment options for patients with glaucoma, according to an article appearing in the September issue of The Archives of Ophthalmology, one of the JAMA/Archives journals.

12 Sep 2004

New device aimed at detecting glaucoma

The physician who revolutionized screening methods for glaucoma nearly 20 years ago has patented a new device aimed at detecting glaucoma, a leading cause of blindness.

10 Sep 2004

New spectral imaging technique will help diagnosis of glaucoma, diabetic retinopathy and age related macula degeneration

A new way of taking pictures of the retina could give medics a powerful new tool in diagnosing and monitoring the most prevalent diseases of the eye - glaucoma, diabetic retinopathy, and age related macula degeneration.

8 Sep 2004

Cymbalta approved for diabetic peripheral neuropathy pain

The U.S. Food and Drug Administration has approved Eli Lilly's Cymbalta, a balanced and potent serotonin and norepinephrine reuptake inhibitor. Cymbalta is the first and only FDA-approved treatment for pain caused by diabetic peripheral neuropathy.

8 Sep 2004

First step in using gene therapy to treat glaucoma

Mayo Clinic researchers have demonstrated they can permanently transfer a functioning gene to targeted tissues within the eye.

2 Sep 2004

Pfizer drug effectively treats overactive bladder symptoms

Women with mixed incontinence, a combination of overactive bladder and stress incontinence, reported a greater treatment benefit for overactive bladder symptoms from DETROL® LA (tolterodine tartrate extended release capsules) than placebo, according to new study results published in the August issue of Urology.

21 Aug 2004

Latinos living in the United States have high rates of eye disease and visual impairment

Researchers found that Latinos had high rates of diabetic retinopathy, an eye complication of diabetes; and open-angle glaucoma, a disease that damages the optic nerve.

9 Aug 2004

Glaucoma News and Research

Latest Glaucoma News and Research

Oak Ridge technology used to understand semiconductor defects helps people at risk of becoming blind

FDA approves Enablex for the treatment of overactive bladder

Confusion over Lasik eye surgery terminology

Detrol LA significantly reduces symptoms of overactive bladder

Instructions provided with medicines is far too small for people with impaired or partially sighted vision to read

Computer use may be linked to the development of glaucoma

McGuinty Government introduces changes to eye care services

Drug-loaded contact lenses to treat eye diseases

A unique new non-invasive technique for high resolution optical imaging of the eye

Significance of central corneal thickness on the management of glaucoma

THC in marijuana may block the spread of forms of cancer causing herpes viruses

Cancer drug effective at treating lupus

New glaucoma risk assessment principles help physicians decide who needs treatment

Thickness of the cornea an important factor in considering treatment options for patients with glaucoma

New device aimed at detecting glaucoma

New spectral imaging technique will help diagnosis of glaucoma, diabetic retinopathy and age related macula degeneration

Cymbalta approved for diabetic peripheral neuropathy pain

First step in using gene therapy to treat glaucoma

Pfizer drug effectively treats overactive bladder symptoms

Latinos living in the United States have high rates of eye disease and visual impairment

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Glaucoma News and Research

Latest Glaucoma News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in